Skip to content
Screener

NewMarket NEU Petroleum Additives — Research, development, and testing expenses

Similar metrics at other companies

Ashland logo
ASHSpecialty Additives — Research And Development Expense
$4M+33.3%
Beam Therapeutics logo
BEAMExternal Research And Development Expenses — Research And Development Expense
$30.08M-12.6%
Helios Technologies logo
HLIOUnallocated Expenses — Research And Development Expense
$0
Solid Biosciences Inc. logo
SLDBInternal Research And Development Expense — Research And Development Expense
$9.06M+33.9%
Disc Medicine logo
IRONInternal Research And Development — Research And Development Expense
$11.31M+67.6%
Dianthus Therapeutics logo
DNTHDiscovery Expenses — Research And Development Expense
$1.36M+51.4%

Other financials

Income statement

See full
Revenue$747.1M+7.0%
Gross profit$242.4M+9.7%
Operating income$163.7M+14.3%
Net income$133.8M+20.2%
EPS (diluted)$14.54+22.8%

Balance sheet

See full
Cash & equivalents$93.6M+33.2%
Total debt$939.9M+2.3%
Total equity$1.8B+14.1%
Total assets$3.6B+13.4%

Cash flow

See full
Operating cash flow$162.1M+0.6%
CapEx$27.4M+68.2%
Free cash flow$134.7M-6.9%

Valuation

See full
Market cap$8.11B+19.5%
Enterprise value$8.95B+17.3%
P/E18.7×+4.6×
P/S+0.5×

Profitability

See full
Gross margin31.5%-1.2pp
Operating margin20%-1.8pp
Net margin15.8%-1.5pp
FCF margin17.3%-1.6pp

Returns & leverage

See full
Return on equity25.1%-8.6pp
Debt / equity0.5×-0.1×
Current ratio2.3×-0.4×

Where this comes from

Reported directly by NewMarket in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The source filing: NewMarket’s 10-Q, filed July 30, 2026.

Filed
Jul 30, 2026, 8:42 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001282637-26-000016
(in thousands)Second Quarter Ended June 30, 2026Second Quarter Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Petroleum additives
Net sales$675,573$653,875$1,285,391$1,299,429
Cost of goods sold(463,188)(448,474)(872,626)(886,220)
Research, development, and testing expenses(30,388)(32,374)(62,024)(65,550)
Other segment items(32,627)(33,192)(66,372)(65,717)
Petroleum additives segment operating profit149,370139,835284,369281,942
Specialty materials
Net sales67,16542,037125,30695,758

Item 1. Financial Statements (unaudited)

FAQ

What is NewMarket's petroleum additives — research, development, and testing expenses?
NewMarket (NEU) reported petroleum additives — research, development, and testing expenses of -$30.39M in Q2 2026.
How has NewMarket's petroleum additives — research, development, and testing expenses changed year-over-year?
NewMarket's petroleum additives — research, development, and testing expenses increased by 6.1% year-over-year, from -$32.37M to -$30.39M.
What is the long-term trend for NewMarket's petroleum additives — research, development, and testing expenses?
Over 3 years (2022 to 2025), NewMarket's petroleum additives — research, development, and testing expenses has grown at a -2.0% compound annual growth rate (CAGR), from -$140.25M to -$132.09M.
What does petroleum additives — research, development, and testing expenses mean?
This metric tracks the investment in research, development, and testing activities dedicated to innovating and improving petroleum additive formulations. It reflects the company's commitment to maintaining a competitive edge through technological advancement and product performance enhancements. High levels of expenditure indicate a focus on long-term product differentiation and market leadership.

Ask your AI about NewMarket's petroleum additives — research, development, and testing expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude